🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Loss of response of the Adalimumab biosimilar compared with the original dr...
Status
Terminated
Location
Hospital Universitario Virgen Macarena
Start Date
2019-10-10
Trial ID
NCT04131322
Treatments Being Tested
This study is a real - world clinical research of adalimumab. The project p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05
Trial ID
NCT07564505
Treatments Being Tested
This study is a real-world clinical study of adalimumab. The project plans ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05
Trial ID
NCT07529925
Treatments Being Tested
The purpose of this study was to determine how effective and safe the study...
Status
Completed
Location
Arizona Arthritis & Rheumatology Associates, P.C.
Start Date
2016-06-06
Trial ID
NCT02760407
Treatments Being Tested
GSK2800528 is being developed as a human anti-tumor necrosis factor (TNF) a...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-07-10
Trial ID
NCT01899755
The goal of this clinical trial is to learn whether children and young adul...
Status
Not Yet Recruiting
Location
University of California, Los Angeles
Start Date
2026-09
Trial ID
NCT07699107
Treatments Being Tested
Investigators hypothesize that TNFi is superior to SC MTX in preventing str...
Status
Recruiting
Location
The Chinese University of Hong Kong, Prince of Wales Hospital
Start Date
2026-03-16
Trial ID
NCT07486843
Treatments Being Tested
The proposed study is a stratified, block-randomized, double-masked, contro...
Status
Completed
Location
University of California, Davis
Start Date
2020-03-15
Trial ID
NCT03816397
Treatments Being Tested